Recon Technology does not pass the ethical screen. The binding factor is interest/revenue 10.9%.
Recon Technology Ltd
RCON · NASDAQ · USD · Market cap $35M · 188 employees
Recon Technology, Ltd.
FAIL · Does not pass the screenPrice as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 12:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price0.84 USD at the 4 Nov 2026 close
- Our regime readDistribution, as of 4 Nov 2026
- Ethical screenDoes not pass
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-04).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Recon Technology Ltd holds its Distribution at $0.84. Consolidating, no directional conviction, held for 33 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 33 days |
| Price at the screen | $0.84 |
| Valuation | N/A trailing · -0.34 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.52 |
Five Screens, Shown in Full
Does not pass. Interest/revenue 10.9%
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 7.27% | Below 33% | Interest-bearing debt is just 7.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 15.95% | Below 33% | Cash held in interest-bearing accounts and securities is 15.9% of assets, under the one-third limit. | Pass |
| Receivables | 26.91% | Below 49% | Money owed to the company is 26.9% of assets, under the 49% limit. | Pass |
| Revenue purity | 10.87% | Below 5% | 10.9% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Recon Technology does not pass the ethical screen. The binding factor is interest/revenue 10.9%.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Recon Technology clears the business-activity screen and the figures we can measure look clean, but its income-purity figure is still pending, so the verdict is not final yet.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Follow this verdict
Get an email when RCON's ethical verdict changes
Today RCON does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
| Forward P/E | -0.3x |
| EPS, trailing | -0.44 |
| EPS, forward | -1.14 |
| Revenue growth | +102.2%growing very fast |
| Profit margin | -25.5%currently unprofitable |
| Return on equity | -6.5%not currently earning a positive return on equity |
| FCF yield | 178.38% |
| Debt to equity | 0.08minimal debt: a conservative balance sheet |
| Current ratio | 4.24comfortably covers its short-term bills |
| Beta | 1.52much more volatile than the market |
| Short interest, float | 0.00% |
| 52-week range | 0.38 - 7.16 |
| Moat | NONE |
| Market cap | $35M |
| Employees | 188 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeRCON trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%. Since the last review it dropped out of the Titan Ethical 500.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading oversold. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 232.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 27.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 71%. Our forward projection puts the odds of a 10% gain over the next month near 28%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-07-30 | Rich McCormick | Republican | sell | 1K–15K |
| 2026-07-30 | Rich McCormick | Republican | sell | 1K–15K |
| 2026-07-20 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-07-07 | Ro Khanna | Democrat | buy | 15K–50K |
| 2026-07-07 | Ro Khanna | Democrat | buy | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $0.79 | -26.0% | · | $741 | -26.0% |
| 2 months | $0.86 | -32.0% | · | $680 | -32.0% |
| 3 months | $1.24 | -52.8% | · | $472 | -52.8% |
| 6 months | $1.30 | -55.0% | · | $450 | -55.0% |
| 1 year | $2.04 | -71.3% | · | $287 | -71.3% |
| 2 years | $1.35 | -56.7% | · | $433 | -56.7% |
| 3 years | $7.38 | -92.1% | · | $79 | -92.1% |
| 5 years | $112.32 | -99.5% | · | $5 | -99.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever RCON does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.